J
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
Price:
8.42
CNY
-0.47%
Market Closed
Market Cap:
¥3.5B
Relative Value
The Relative Value of one Jiangxi Synergy Pharmaceutical Co Ltd stock under the Base Case scenario is 8.82 CNY. Compared to the current market price of 8.42 CNY, Jiangxi Synergy Pharmaceutical Co Ltd is Undervalued by 5%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
8.82
CNY
Undervaluation 5%
J
Multiples Across Competitors
Competitors Multiples
Jiangxi Synergy Pharmaceutical Co Ltd Competitors
Jiangxi Synergy Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
J
|
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
|
3.5B CNY | 4.3 | 37.4 | 44.6 | 44.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
975.1B USD | 14.9 | 47.2 | 31.8 | 33.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.4B USD | 6.3 | 22.2 | 15.4 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP | 5.5 | 31.7 | 17.5 | 24.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.1B USD | 4.7 | 16.8 | 10.5 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.9B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
